1 Magnificent ETF I'm Buying Hand Over Fist in 2026

Source Motley_fool

Key Points

  • The Schwab U.S. Dividend Equity ETF holds 100 top high-yielding dividend growth stocks.

  • Dividend growers have historically delivered the highest total returns.

  • The fund also helps further diversify my dividend portfolio.

  • 10 stocks we like better than Schwab U.S. Dividend Equity ETF ›

I typically buy individual stocks. However, I've started investing in more exchange-traded funds (ETFs) over the past year. They help me further diversify my portfolio and sharpen my focus on my highest conviction ideas.

Dividend stocks are one of my highest conviction investments due to their historical outperformance over companies that don't pay dividends. The Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) does a magnificent job tracking the best ones, which is why I have been buying the ETF hand over fist this year.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

A hand writing out exchange-traded fund.

Image source: Getty Images.

Focused on the best-of-the best

The Schwab U.S. Dividend Equity ETF has a very straightforward investment strategy. It aims to closely track the performance of the Dow Jones U.S. Dividend 100 Index. That index screens companies to find those with higher yields, a consistent record of dividend payments, and relatively strong financial metrics compared to their peers. Among its quality screens are a stock's dividend yield and five-year dividend growth rate. The net result is an index that tracks 100 of the highest-quality, high-yielding dividend stocks.

The index reruns its screen each year and will jettison lower-quality dividend stocks in favor of those with better metrics, ensuring it tracks the top 100 high-yielding dividend stocks. At its last reshuffle, the index booted 22 existing stocks and added 25 new ones. Following the revamp, the index's holdings had an average yield of 3.4% (the same as before and well above the S&P 500's 1.1% yield) and had grown their dividends at a 9.4% annualized rate over the last five years, up from 8.6%.

That dual focus on yield and dividend growth is worth noting. Over the long term, dividend growth stocks have delivered the highest return by dividend policy:

Dividend status

Average annual total return

Dividend Growers & Imitators

10.2%

Dividend Payers

9.2%

Equal-Weight S&P 500 Index

7.7%

No Change in Dividend Policy

6.9%

Dividend Cutters & Eliminators

-1%

Dividend Non-Payers

4.2%

Data source: Ned Davis Research and Hartford Funds.

Unsurprisingly, the Schwab U.S. Dividend Equity ETF's concentrated focus on the best high-yielding dividend growth stocks has yielded strong total returns. Since its inception in 2011, the ETF has delivered an annualized total return of 13.3%.

Further diversifying my dividend investments

The strong returns of dividend growth stocks are why I own several in my portfolio. However, I don't own them all. That's why I also like to hold the Schwab U.S. Dividend Equity ETF, which I see as a good complement to my existing dividend stock portfolio. It helps to further diversify and deepen my holdings.

For example, I only hold four of its 10 largest holdings. Because of that, I'm missing out on some high-quality dividend stocks. Of note, four of its top 10 holdings are healthcare stocks, none of which I currently own. One of those holdings is UnitedHealth Group (NYSE: UNH). The health insurance giant has paid a dividend since 1990 and has increased its payout for the last 16 consecutive years, including a recent 5% increase. It currently yields 2.2%. By investing in SCHD, I'm adding exposure to higher-quality dividend stocks, such as UnitedHealth.

I plan to continue buying this outstanding ETF

I've purchased some shares of the Schwab U.S. Dividend Equity ETF almost every month this year. It delivers above-average income, strong returns, and enhances my diversification. That's why I expect to continue adding to my position this year.

Should you buy stock in Schwab U.S. Dividend Equity ETF right now?

Before you buy stock in Schwab U.S. Dividend Equity ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab U.S. Dividend Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $400,101!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,212,683!*

Now, it’s worth noting Stock Advisor’s total average return is 911% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of July 2, 2026.

Matt DiLallo has positions in Schwab U.S. Dividend Equity ETF. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Japan, South Korea Stocks Rise in Early Trade; Samsung, SK Hynix Soar, SoftBank, Kioxia Track GainsTradingKey - Both the KOSPI and Nikkei 225 indexes opened higher, led by gains in Samsung Electronics and SK Hynix, with SoftBank and Kioxia following suit.During the Asian session on June 30, both Ja
Author  TradingKey
6 Month 30 Day Tue
TradingKey - Both the KOSPI and Nikkei 225 indexes opened higher, led by gains in Samsung Electronics and SK Hynix, with SoftBank and Kioxia following suit.During the Asian session on June 30, both Ja
placeholder
XRP Price Prediction for July 2026: Can Buyers Finally Break the Downtrend?XRP (XRP) price trades near $1.05, caught between a year-long downtrend and a sudden burst of buying.July has historically rewarded XRP holders. This year the month arrives with on-chain accumulation
Author  Beincrypto
6 Month 30 Day Tue
XRP (XRP) price trades near $1.05, caught between a year-long downtrend and a sudden burst of buying.July has historically rewarded XRP holders. This year the month arrives with on-chain accumulation
placeholder
Gold Price Forecast: Iran Denies Trump Negotiation Plan, Gold Price May Fall to $3,500TradingKey - As of today's (July 1st) Asian morning session, gold ( XAUUSD) prices maintained a weak intraday decline. After stabilizing above $4,000 at yesterday's close, the gold price broke below $
Author  TradingKey
Yesterday 03: 40
TradingKey - As of today's (July 1st) Asian morning session, gold ( XAUUSD) prices maintained a weak intraday decline. After stabilizing above $4,000 at yesterday's close, the gold price broke below $
placeholder
What to Expect From Ethereum (ETH) in July 2026Ethereum (ETH) enters July 2026 trading near $1,570, close to multi-month lows, after recording its first run of three consecutive red quarterly candles in its history.On-chain data and price charts n
Author  Beincrypto
Yesterday 05: 39
Ethereum (ETH) enters July 2026 trading near $1,570, close to multi-month lows, after recording its first run of three consecutive red quarterly candles in its history.On-chain data and price charts n
placeholder
Meta Compute Launch Sends AI Compute Stocks Tumbling GloballyMeta’s plan to sell surplus computing power hit chip stocks hard on Wall Street. Meta’s own shares climbed nearly 9% on the news.The announcement flipped years of assumed AI compute scarcity into a su
Author  Beincrypto
11 hours ago
Meta’s plan to sell surplus computing power hit chip stocks hard on Wall Street. Meta’s own shares climbed nearly 9% on the news.The announcement flipped years of assumed AI compute scarcity into a su
goTop
quote